XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series T Preferred Stock
Preferred Stock
Series Seed Preferred Stock
Common Stock
Additional Paid-in Capital
Subscription Receivable
Noncontrolling Interest
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2021 $ 5,286,667 $ 983,852 $ 1,707,990 $ 328 $ 39,246,724 $ (367,831) $ (4,127) $ (18,938,969) $ 27,914,634
Balance at the beginning (in shares) at Dec. 31, 2021 9,272,044 482,211 10,247,938 32,865,193          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Sale of common stock       $ 4 7,101,429 $ 367,831     $ 7,469,264
Sale of common stock (in shares)       401,645         401,645
Exercise of stock options         38,035       $ 38,035
Exercise of stock options (in shares)       7,927         7,927
Stock compensation expense         3,993,424       $ 3,993,424
Offering costs (Restated)         (4,955,461)       (4,955,461)
Noncontrolling interest             (9,124) 9,124  
Conversion to Common Stock   $ (218) $ (1,234)   1,452        
Conversion to Common Stock (in shares)   (107) (7,402) 26,897          
Net Income (Loss)               (9,332,106) (9,332,106)
Balance at the end at Dec. 31, 2022 $ 5,286,667 $ 983,634 $ 1,706,756 $ 332 45,425,603   (13,251) (28,261,952) 25,127,789
Balance at the end (in shares) at Dec. 31, 2022 9,272,044 482,104 10,240,536 33,301,662          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance at the end (Restated) $ 5,286,667 $ 983,634 $ 1,706,756 $ 332 45,425,603   (13,251) (28,261,951) 25,127,790
Balance at the end (in shares) (Restated) 9,272,044 482,104 10,240,536 33,301,662          
Sale of common stock       $ 3 10,162,061       $ 10,162,064
Sale of common stock (in shares)       455,261         570,037
Exercise of stock options       $ 1 86,389       $ 86,390
Exercise of stock options (in shares)       135,776         133,805
Stock compensation expense         7,057,402       $ 7,057,402
SeedInvest Acquisition       $ 7 23,999,990       23,999,997
SeedInvest Acquisition (in shares)       960,000          
Offering costs (Restated)         (4,719,370)       (4,719,370)
Net Income (Loss)               (16,375,478) (16,375,478)
Balance at the end at Dec. 31, 2023 $ 5,286,667 $ 983,634 $ 1,706,756 $ 343 $ 82,012,075   $ (13,251) $ (44,637,430) $ 45,338,794
Balance at the end (in shares) at Dec. 31, 2023 9,272,044 482,104 10,240,536 34,852,699